64. Comparison of the effects of topical and intravenous administration of tranexamic acid on postoperative blood loss in single-level posterior lumbar interbody fusion
Tranexamic acid (TXA), a synthetic antifibrinolytic drug, competitively blocks the lysine-binding sites of plasminogen, plasmin, and tissue plasminogen activator, thus reducing bleeding. Intravenous TXA has been used to effectively reduce perioperative blood loss in spinal surgery. However, high-dos...
Saved in:
Published in | North American Spine Society journal (NASSJ) Vol. 18; p. 100402 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!